| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ra Medical Systems, Inc. | CFO | Common Stock | 21.7K | $8.68K | $0.40 | May 20, 2022 | Direct |
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Common Stock | 2.5K | $5K | $2.00 | Aug 21, 2025 | Direct |
| Brooklyn ImmunoTherapeutics, Inc. | Chief Financial Officer | Stock Option (right to buy) | 665K | Jun 3, 2022 | Direct | ||
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Stock Options (right to buy) | 30K | Sep 3, 2025 | Direct | ||
| Calidi Biotherapeutics, Inc. | Chief Financial Officer | Warrant (right to buy) | 2.5K | Aug 21, 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CLDI | Calidi Biotherapeutics, Inc. | Sep 3, 2025 | 1 | $0 | 4 | Sep 5, 2025 | Chief Financial Officer |
| CLDI | Calidi Biotherapeutics, Inc. | Aug 21, 2025 | 2 | $5K | 4 | Aug 25, 2025 | Chief Financial Officer |
| CLDI | Calidi Biotherapeutics, Inc. | Jun 17, 2024 | 1 | $0 | 4 | Jun 20, 2024 | Chief Financial Officer |
| CLDI | Calidi Biotherapeutics, Inc. | Oct 30, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Chief Financial Officer |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Chief Financial Officer |
| ERNA | Brooklyn ImmunoTherapeutics, Inc. | May 31, 2022 | 0 | $0 | 3 | Jun 1, 2022 | Chief Financial Officer |
| RMED | Ra Medical Systems, Inc. | May 20, 2022 | 1 | -$410 | 4 | May 24, 2022 | CFO |
| RMED | Ra Medical Systems, Inc. | Nov 20, 2021 | 2 | -$7.03K | 4 | Nov 24, 2021 | CFO |